Literature DB >> 21084445

Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.

Michiko Hori1, Yuichiro Shimizu, Seiji Fukumoto.   

Abstract

Fibroblast growth factor 23 (FGF23) was identified in 2000. Since then, FGF23 has been found to physiologically regulate phosphate metabolism and aberrant actions of FGF23 results in several disorders of phosphate and bone metabolism. In addition, FGF23 plays an important role in the development of chronic kidney disease-mineral and bone disorder. However, further investigations are necessary, especially with regard to the regulation of FGF23 expression. In this minireview, we focus on the physiological and pathophysiological significance of FGF23 in phosphate and bone metabolism.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21084445     DOI： 10.1210/en.2010-0800

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


  25 in total

1.  Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.

Authors:  Richard D Semba; Jeffrey C Fink; Kai Sun; Anne R Cappola; Mansi Dalal; Candace Crasto; Luigi Ferrucci; Linda P Fried
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway.

Authors:  Paula Suarez-Bregua; Eva Torres-Nuñez; Ankur Saxena; Pedro Guerreiro; Ingo Braasch; David A Prober; Paloma Moran; Jose Miguel Cerda-Reverter; Shao Jun Du; Fatima Adrio; Deborah M Power; Adelino V M Canario; John H Postlethwait; Marianne E Bronner; Cristian Cañestro; Josep Rotllant
Journal:  FASEB J       Date:  2016-10-24       Impact factor: 5.191

Review 3.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

4.  FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.

Authors:  Yue Ma; Beth J Kirby; Nicholas A Fairbridge; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

5.  Regulation of mineral metabolism by lithium.

Authors:  Hajar Fakhri; Ganesh Pathare; Abul Fajol; Bingbing Zhang; Thomas Bock; Reinhard Kandolf; Erwin Schleicher; Jürg Biber; Michael Föller; Undine E Lang; Florian Lang
Journal:  Pflugers Arch       Date:  2013-09-07       Impact factor: 3.657

6.  Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization.

Authors:  Yue Ma; Manoharee Samaraweera; Sandra Cooke-Hubley; Beth J Kirby; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2014-03-06       Impact factor: 4.736

7.  Phosphate metabolism and vitamin D.

Authors:  Seiji Fukumoto
Journal:  Bonekey Rep       Date:  2014-02-05

Review 8.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

Review 9.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.

Authors:  Shu Feng; Olga Dakhova; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.